GlassScriptPhysician profile
Michael L Vick
NPI 1073503165
$1,947.94
in general payments reported to CMS, 2019-2025
18 companies · $677 in 2025
The $677 reported for 2025 was more than what a typical Otolaryngology provider received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $239 · 2020: $82.76 · 2021: $100 · 2022: $315 · 2023: $277 · 2024: $257 · 2025: $677.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,211.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,210.71 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Inspire Medical Systems, INC. | $830.82 | 2022-2025 | Inspire |
| Genzyme Corporation | $247.15 | 2021-2025 | |
| Regeneron Healthcare Solutions, INC. | $170.29 | 2019-2025 | Dupixent |
| Stryker Corporation | $139.58 | 2019-2022 | |
| Intersect Ent, INC. | $118.69 | 2019-2021 | |
| Glaxosmithkline, LLC. | $117.91 | 2025 | Nucala |
| Optinose US, INC. | $103.32 | 2019-2024 | |
| Alk-Abello, INC | $42.41 | 2019-2025 | Neffy, Grastek, Odactra |
| Cochlear Americas | $22.86 | 2022 | |
| Ambu INC. | $21.16 | 2020 | |
| Axogen | $20.84 | 2019 | |
| Cumberland Pharmaceuticals, INC. | $19.99 | 2023 | Caldolor |
| Merck Sharp & Dohme LLC | $18.64 | 2023 | |
| Medtronic, INC. | $18.28 | 2024 | Sinuva |
| Aerin Medical INC. | $17.19 | 2024 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Baxter Healthcare | $16.50 | 2022 | |
| Smith+Nephew, INC. | $14.26 | 2019 | |
| Fortovia Therapeutics, INC. | $8.05 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Vick listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.